Clinical trial
Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
NCT00182429 · McMaster University, Other · Completed
Key facts
| NCT number | NCT00182429 |
|---|---|
| Title | Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment |
| Official title | Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD) |
| Lead sponsor | McMaster University, Other |
| Collaborators | The Physicians' Services Incorporated Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Clostridium Enterocolitis, Antibiotic-Associated Diarrhea, Pseudomembranous Colitis, Pseudomembranous Enterocolitis, Pseudomembranous Enteritis |
| Intervention type | Drug |
| Interventions | Metronidazole and Rifampin |
| Enrollment | 100 |
| Start date | Feb 1, 2004 |
| Primary completion | Apr 30, 2005 |
| Completion | Dec 31, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 15, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: